Zenas BioPharma (ZBIO) Research & Development (2023 - 2026)
Zenas BioPharma (ZBIO) recorded Research & Development of $62.91 million in Q2 2026, up 46.2% from $43.03 million a year earlier and up 4.1% from the prior quarter.
Powered by 
Analysis
Zenas BioPharma (ZBIO) Research & Development (2023 - 2026) Analysis & Trends
On a TTM basis, Zenas BioPharma's Research & Development came in at $213.47 million as of Jun 30, 2026, up 32.9% year-over-year; for FY2025, it came in at $168.06 million, up 20.8% from FY2024.
- Across earlier years, Research & Development came in at $139.14 million in FY2024 (+131.8%) and $60.03 million in FY2023.
- The Q2 2026 figure is the highest quarterly Research & Development in data going back to Q3 2023.
- On a year-over-year basis, Research & Development has increased for eight consecutive quarters, with growth averaging 77.0% over the last eight quarters.
- Across the past five years, year-over-year growth in Research & Development ran from 2.6% in Q3 2025 to 258.5% in Q3 2024.
- Per Business Quant, the preceding three quarters came in at $60.44 million (Q1 2026), $55.72 million (Q4 2025) and $34.4 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 618.58 Bn | 537.11 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 507.51 Bn | 480.62 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 364.48 Bn | 318.85 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.05 Bn | 261.04 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.61 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 235.60 Bn | 191.00 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.42 Bn | 165.62 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.40 Bn | 117.05 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Zenas BioPharma | 1.82 Bn | 1.14 Bn | - | 62.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 62.91 Mn |
| Mar 31, 2026 | 60.44 Mn |
| Dec 31, 2025 | 55.72 Mn |
| Sep 30, 2025 | 34.40 Mn |
| Jun 30, 2025 | 43.03 Mn |
| Mar 31, 2025 | 34.92 Mn |
| Dec 31, 2024 | 49.16 Mn |
| Sep 30, 2024 | 33.53 Mn |
| Jun 30, 2024 | 33.81 Mn |
| Mar 31, 2024 | 22.65 Mn |
| Dec 31, 2023 | 20.42 Mn |
| Sep 30, 2023 | 9.35 Mn |
API Access
Zenas BioPharma Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ZBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ZBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ZBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();